Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
126.71
-3.18 (-2.45%)
At close: Mar 14, 2025, 4:00 PM
126.19
-0.52 (-0.41%)
After-hours: Mar 14, 2025, 7:59 PM EST
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
114,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
219.76B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 114,000 | 0 | - |
Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
Dec 31, 2012 | 91,000 | 0 | - |
Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
Dec 31, 2005 | 59,735 | -865 | -1.43% |
Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
Dec 31, 2003 | 72,200 | 381 | 0.53% |
Dec 31, 2002 | 71,819 | 393 | 0.55% |
Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
Dec 31, 1999 | 57,100 | 864 | 1.54% |
Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
Dec 31, 1995 | 50,241 | 777 | 1.57% |
Dec 31, 1994 | 49,464 | -195 | -0.39% |
Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
ABT News
- 7 days ago - Strong Earnings Lift Abbott Laboratories Shares - FXEmpire
- 9 days ago - The Dividend Aristocrats Ranked By Quality Scores: March 2025 - Seeking Alpha
- 10 days ago - Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion - Business Wire
- 10 days ago - Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD - Business Wire
- 15 days ago - My Best Dividend Aristocrats For March 2025 - Seeking Alpha
- 21 days ago - Abbott Declares 405th Consecutive Quarterly Dividend - PRNewsWire
- 5 weeks ago - Here are the best performing dividend aristocrats stocks in 2025 - Invezz
- 5 weeks ago - Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care - PRNewsWire